Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

TNXPTNXP
3 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in TONIX PHARMACEUTICALS HLDG C

BALYASNY ASSET MANAGEMENT L.P. holds 132,591 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $1.7M as of 2026-Q2. The position was decreased (-57.6% shares). TNXP represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$1.7M

Current Shares

132,591

Total Value Change

-$1.2M

Total Shares Change

-52,761

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
132,591
-57.6%
$1.7M0.0%$12.76
0
2026-Q1
Increased
313,082
+68.9%
$4.3M0.0%$13.94
40
2025-Q4
New
185,352
-
$2.9M0.0%$15.82
36

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used